Valerie W. Collins, PT, CLT-LANA and Amber Cobia, PT, DPT, CLT will introduce the audience to the anatomy and physiology of the lymphatic system, who is at risk of developing lymphedema, and therapeutic interventions for both mild and severe cases of lymphedema.

Introduction and discussion of supportive care programs in a "home away from home" for patients during their cancer journey.

Cancer touches all of our lives. For many Native communities, fears of cancer risk from environmental sources beyond their control are common. Some researchers, usually unaware of Native community concerns, can harbor the perspective that Native communities could be fruitful populations for studying the genetic risks of cancer. This webinar will help both sides of this chasm understand the other's point of view, hopefully leading to more effective communications and priority setting.

Denise Spector, PhD, MPH, ANP, RYT, will provide an overview of integrative oncology which includes evidence-based strategies for helping to mitigatecommon cancer symptoms and cancer treatment-related side effects, as well as strategies that may improve one's overall healthand well-being along the cancer care continuum.

Farrell Wiggins MS, OTR/L and Alexis Petteway, OTR/L will provide insight into Occupational Therapy’s unique role in cancer rehabilitation. They will explore the benefits of receiving OT in both the inpatient and outpatient settings. Importantly, they will also discuss the how occupational therapists measure and address cancer and chemotherapy related symptoms and occupational challenges in cancer survivors.

Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.

Join our conversation on how to provide patient centered care for LGBTQ patients and families from registration through diagnosis, treatment and survivorship.

Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.

Siddharth Sheth, DO, MPH, will provide a brief overview of clinical factors relevant to head and neck cancers and basic management. Themain focus will be the current use of technologies that aid with the diagnosis, treatment selection, and monitoring of patientswith head and neck cancers. This includes next generation sequencing assays for DNA sequencing, RNA sequencing, andcirculating tumor DNA. The goal of the presentation is for providers to be comfortable with ordering and basic interpretation ofthese tests.

Cindy Kelly, FNP-BC, ACHPN, and Vineeta Rao, PharmD, BCPS, will provide a review of opioid and nonopioid treatment options for cancer-related pain.  This presentation will address patients with cancer and substance use disorder and also cancer patients that are in remission, but still present with persistent pain.

Megan McElfresh, PA-C, will provide an overview of the pathophysiology, diagnosis, prevention, and treatment of graft vs host disease post hematopoietic stem cell transplant.

The Adolescent and Young Adult (AYA) years bring with them many developmental milestones. Among those milestones are the exploration of sexuality, sexual identity, and romantic relationships. Although we might think otherwise, AYAs with cancer are engaging in sexual activity at rates similar to their peers, but face challenges that their peers do not (increased risk of infection, bleeding, etc). Studies have shown that AYAs want sexual health information. It’s incumbent upon cancer care providers to initiate these conversations, but many feel ill prepared. Let's talk about sex.

Donald Warne, MD, MPH, will describe health disparities and inequities related to American Indian cancer control. We will explore the legal basis for federally-funded health services to American Indians and the complexity of health policy at the federal, state and tribal levels that impact cancer control. We will provide a framework for health equity and a path forward to improve outcomes.

Lauren M.B. Burke, MD, and Katrina A. McGinty, MD, will provide an overview of different imaging modalities for imaging the abdomen, as well as some of their common indications and patient-specific limitations. They will also discuss an overview of commonly used imaging modalities with an emphasis on understanding different modalities' strengths and limitations. The goal is to provide instruction on deciding when different imaging modalities and tests are appropriate for different pathologies.

Lara Novak, PA-C, will provide an overview of acute radiation side effects from head to toe.

Arthur Blackstock, Jr., MD, will discuss protons entering the state, the expanded use of Stereotactic Body Radiation Therapy (SBRT), and perhaps review the impact of PSMA imaging in Radiation Oncology.

This presentation will be a detailed explanation of key cancer registry functions and highlight the data it contains.

A review of several of the most common clinical emergencies that occur with malignancy and how to manage them, with tips on management and discussion of common misconceptions.

Katie Riffle, MSN, FNP-BC, provides a quick glimpse into what procedures Vascular Interventional Radiology (VIR) offers, reasons behind clinical decisions and how to manage patients after. She will also discuss ways to trouble shoot CVADs, drains, and feeding tubes.

Ostomies, tubes, and drains are often necessary in the adult oncology population for various reasons and clinical scenarios. This presentation will serve as an overview of the different types of ostomies, as well as frequently used tubes and drains, such that APPs across all oncology disciplines will be familiar with their necessity, use, and common complications.

In this webinar, we will discuss the definition and use of electronic patient-reported outcomes (ePROs) and mobile health technology in optimizing postoperative cancer care.

Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture will discuss several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more. We will walk through a patient case to highlight practical suggestions for successful implementation of oral chemotherapy for patients.

Genetic sequencing technologies are increasingly applied in the oncology setting for a variety of purposes. Genetic testing of tumor specimens can help clarify a diagnosis and inform targeted therapies. Circulating tumor DNA can be detected in blood samples and can also guide therapy as well as monitoring for response to treatment or recurrence. Five to ten percent of cancers are the result of an underlying hereditary syndrome. Dedicated germline (i.e. hereditary) genetic tests are required to identify these syndromes, but other genetic tests may provide clues about the chance of a hereditary syndrome. Inappropriate use of other types of genetic testing to assess germline risk can result in harm to patients. We propose to provide education about various oncology genetic tests and their uses, with an emphasis on what those tests may (or may not) tell us about underlying hereditary risk. We will illustrate this with case examples, including a recent case referred to us who underwent prophylactic surgeries after being told she had BRCA1/2 associated hereditary breast and ovarian cancer syndrome following incorrect ordering of a test that did not address germline risk and misinterpretation of the results.

Join Transfusion Medicine and Blood Bank Fellow, Mariama Evans, MD, for a review of transfusion reactions and their laboratory workup. Specific topics to include the most common transfusion reactions seen in cancer patients and the laboratory techniques utilized, such as Direct Antiglobulin Test (DAT) and elutions.

A comprehensive overview of past, present, and future management of systemic therapy for muscle-invasive bladder cancer and renal cell carcinoma. Includes updates on neoadjuvant and adjuvant therapy, as well as organ preservation techniques.

This lecture will highlight the important role of primary care providers and provide helpful information that will empower them to confidently provide comprehensive and collaborative care to patients living with breast cancer and beyond.

Shetal A. Patel, MD, PhD will provide an update on recent data impacting the management of lung cancer.

Forming relationships and partnerships with tribal communities are crucial in addressing cancer health disparities among American Indian & Alaska Native populations. Dr. Myra Parker and Craig Dee describe how established trust and relationships with tribal entities led to the development and implementation of tribally-driven strategies to address cancer among Washington State Tribes.

Cryotherapy is already an established treatment for other chemotherapy induced conditions such as alopecia and mouth mucositis. This course will explore the evidence for using this low-cost intervention to reduce the incidence/severity of chemotherapy-induced neuropathy.

More than ever before, there are rising cases of colon and rectal cancers among young people. Updated recommendations have lowered the age of screening to age 45 from standard age of 50.

Psycho-oncology or psychosocial oncology is a sub-specialty of oncology that addresses the psychological, behavioral, emotional, and social issues that arise for cancer patients and their families. A cancer diagnosis, the treatments that follow, and the adverse effects of cancer treatments are all very distressing for patients. Psycho-oncology includes providers from various disciplines that work together as a team to best support the complex needs people face when struggling with cancer. This lecture focuses on the psychiatric care of patients with cancer and looks at the common psychiatric syndromes seen in psycho-oncology, appropriate medications and treatment plans, and how psychiatry can best support people with cancer. Untreated or poorly managed psychiatric syndromes, such as depression and anxiety, can have a profound negative impact on decision-making, compliance, and quality of life during cancer care.

Hannah E. Woriax, MD, will review several case scenarios and patient archetypes that have had their treatment course changed drastically due to recent landmark research studies. Dr. Woriax will then go through a few scenarios relevant to my current patient population specifically. Based on these patient scenarios, she will then discuss potential research possibilities for the future.